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Endothelin-1 inhibits cytokine-stimulated transcription of inducible
nitric oxide synthase in glomerular mesangial cells. Endothelin-1 (ET-1)
is a potent vasoconstrictor while nitric oxide (NO) has strong vasodilatory
effects. Recent studies have indicated that vasoconstrictors and NO may
mutually modulate their production and/or activity, thus regulating each
other in the context of microcirculatory maintenance. We examined the
question whether ET-1 may affect NO formation by controlling the
expression of the inducible isoform of the NO synthase (iNOS) in cultured
rat glomerular mesangial cells (MC5), as induced by the inflammatory
cytokines, tumor necrosis factor-a (TNF-a) plus interleukin-1J3 (IL-113).
We found that ET-1 in MCs markedly reduced cytokine-induced NO
production (measured as stable NO2—) and inhibited the expression of
iNOS mRNA (Northern blot analysis) and of iNOS protein (Western
blotting). Inhibition of cytokine-stimulated iNOS mRNA expression by
ET-1 was almost complete at the level of gene transcription while
post-transcriptional effects were not detected. The ETA receptor antago-
nist BQ-123 blocked the inhibitory effect of ET-1. The ETA agonist
sarafotoxin 6b (S6b) inhibited, while the ETB agonist sarafotoxin 6c (S6c)
did not inhibit cytokine-initiated iNOS transcription in MCs. The results
demonstrate that ET-1 can strongly inhibit cytokine induction of iNOS
and formation of NO in cultured MCs, and that this action is mediated via
the ETA receptor. While the precise mechanism(s) and biological rele-
vance of this ET-1 effect are presently unclear, it is conceivable that
down-regulation of iNOS by the vasopressor ET-1 may serve in vivo to
prevent massive NO build-up and subsequent vasomotor collapse in the
glomerular capillary tuft. This could help to maintain glomerular ultrafil-
tration in states of endotoxin excess as well as during glomerular forma-
tion and action of TNF-cs and IL-1J3 causing iNOS induction and
subsequent overproduction of NO.
The balance of constricting and relaxing stimuli regulates the
tone of the microvasculature and the hydrostatic pressure in the
glomerular capillary tuft and, thus, contributes to the control of
the glomerular ultrafiltration. Recent studies have shown that
nitric oxide (NO) opposes the potent vasoconstrictor action of
endothelins (ETs) [1, 2] by generating vasodilatory cyclic
guanosine monophosphate (cGMP) [3, 4]. In addition to their
constricting effects on vascular smooth muscle cells (VSMCs) of
the afferent and efferent arterioles and on glomerular mesangial
cells (MCs), ETs are known to stimulate the activity of a
constitutively expressed NO synthase (cNOS) of endothelial cells.
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By increasing the formation of NO, ETs counteract their own
vasoconstrictive effect [5, 6]. ET-dependent activation of cNOS
and NO release are short-lived and thought to serve the minute-
by-minute regulation of the glomerular hydrostatic pressure. In
keeping with this concept is the observation that inhibitors of NO
formation attenuate a transient depressor effect of ET on arterial
blood pressure in rats [71.
Recently, several reports have demonstrated that MCs from
different species possess the inducible form of NOS (iNOS)
[8—13], which is also found in macrophages and VSMCs [14, 15].
This enzyme generates large amounts of NO for a prolonged time
period upon induction by various pro-inflammatory agents and
mediators, such as bacterial endotoxin, tumor necrosis factor-a
(TNF-a) and interleukin-1/3 (IL-1/3). The effects of vasoconstric-
tor substances on the iNOS expression in MCs are presently
unknown. Nakayama et a! [16] reported that the IL-1f3-stimulated
expression of iNOS in VSMCs derived from rat thoracic aorta can
be inhibited by angiotensin II.
The present study was performed to examine whether ET-1
exerts regulatory effects on the expression of iNOS in cultured rat
MCs, as induced by TNF-a plus IL-1f3. We found that ET-1
inhibits the formation of iNOS protein and NO by blocking the
expression of iNOS mRNA at the level of gene transcription
elicited by TNF-a plus IL-1J3. This inhibitory effect of ET-1 is
mediated via the ETA receptor, since it can be mimicked by the
ETA receptor agonist sarafotoxin 6b (S6b) and blocked by pre-
treatment with the ETA receptor antagonist BQ-123.
Methods
Materials
Human recombinant IL-1/3 and ET-1 were purchased from
Boehringer Mannheim (Mannheim, Germany). Human recombi-
nant TNF-a was a gift from BASFIKno1I (Ludwigshafen, Germa-
ny). Sarafotoxins, BQ-123, L-NMMA and chemicals used for the
NO2 determination were purchased from Sigma (Deisenhofen,
Germany). Radioactive products and nylon blotting membranes
were obtained from Amersham Buehler (Braunschweig, Germa-
ny). Tissue culture plastic was from Falcon (Becton-Dickenson,
Heidelberg, Germany), media and sera from Gibco-BRL (Eggen-
stein, Germany).
Mesangial cell preparation and cell culture
For preparation and culture of glomerular MCs from male
Sprague-Dawley rats, standard techniques were used, as described
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Table 1. Synergistic effects of IL-113 and TNF-a on iNOS
mRNA induction
IL-i/I U/mi
Percent
Without TNF-a With TNF-a
0
2
10
25
40
55
70
85
100
2.4
3.9
0.6
7.8
5.3
8.3
17.2
9.5
12.5
2.4
10.2
29.1
58.9
60.6
51.0
72.0
100.0
71.3
MCs were treated with TNF-a (10 ng/ml) and different concentrations
IL-i/I (0 to 100 U/mI) for 15 hours. Data were calculated from videoden-
sitometric analysis of Northern blots revealing INOS mRNA expression
after probing with 32P-labeled iNOS and reprobing for GAPDH mRNA.
Results are given as per cent of maximal ratio of densitometric readings of
iNOS mRNA vs. GAPDH mRNA found for IL-1/3 (85 U/mI) plus TNF-a
(10 ng/ml). The data shown are derived from one representative experi-
ment out of three using MC mRNA from two wells per point. Preparation
techniques for MCs and mRNA are described in Methods.
previously [12, 17, 18]. The outgrowing cells were characterized as
MCs by positive immunocytochemical staining for Thy 1.1 (Sero-
tee, Blackthorn, Bicester, UK) smooth muscle cell actin and
myosin, showing typical MC morphology [17]. MCs were cultured
in Dulbecco's minimal essential medium supplemented with 10%
heat inactivated fetal calf serum (FCS), 2 m glutamate, 5 ng/ml
insulin, 100 U/mI penicillin and I mg/mI streptomycin (all from
Sigma). Cells were used for experiments at subconfluence or
passaged at confluence with trypsin/EDTA (0.05 %I0.02%wt/vol).
To obtain quiescent cells, MCs were maintained in medium
containing 0.5% FCS for four days before cytokine treatment.
MCs were used between passages 8 and 19. In order to find
suitable cytokine concentrations for this study, we performed
dose-response experiments (Table 1) or chose doses used by us
[12, 22] or others [8, 11]. Inmost experiments, the cytokines IL-1/3
and TNF-a were used in concentrations of 25 U/mI and 25 ng/ml,
respectively.
N02 determination in MC supernatants
MCs were grown to subconfluence in six-well plates and were
then conditioned in phenol red-free culture medium for 24 or 48
hours. The N02 content was measured using the Griess colon-
metric method [12, 19]. Briefly, 250 l of supernatant as well as
control medium containing known concentrations of NaNO2 were
mixed with 50 1.d of Griess reagent (25 mi sulphanilamide and 25
mM naphtylethylenediamine) and 25 j.rl 6 M HCI and incubated for
30 minutes in the dark. Optical density was measured at 550 nm
and the N02 content of conditioned medium was calculated
from the curve obtained from NaNO2 standards. N02 levels
were corrected for the total protein content of MC extracts
determined by the Bradford method [20].
Northern hybridization analysis
Total RNA from rat MCs grown to subconfluence in 100 mm
culture dishes was obtained, as described [21, 22]. Twenty micro-
grams total RNA were subjected to electrophoresis in I % agarose
gel containing 1.8% formaldehyde. The separated RNA was
transferred to nylon membranes and fixed by baking at 80°C for
two hours. Next, the RNA was prehybridized (5 X Denhardt's
solution, 5 X SSC, 50 mvi Na3PO4, 0.1% SDS, 250 jsg herring
sperm DNA, 50% formamide) for at least two hours at 42°C and
then hybridized for 12 to 24 hours using the same conditions. For
hybridization, the EcoRI/PstI cut insertion of the plasmid piNOS
B2 [14], a murine iNOS eDNA clone, was used. This 611 bp
fragment, which represents the 5' region of the iNOS eDNA was
32P-labeled by the use of a random priming kit (Boehringer
Mannheim, Germany). The membrane was washed at 42°C (2 X
15 mm with 2 x SSC, 0.1% SDS and at least 30 mm with 0.2 X
SSC, 0.1% SDS) and exposed to X-ray film (Kodak, XAR-5
supplied by Sigma) at —80°C for at least 15 hours. To correct for
variations in RNA content, filters were rehybridized with a
32P-labeled rat glycerine-aldehyde-3-phosphate-dehydrogenase
(GAPDH) probe, which was obtained using a homology-based
reverse transcription-polymerase chain reaction (Gibco, Eggen-
stein, Germany) of MC mRNA with the following primers added
to the reaction mix:
sense: 5' AATGCATCCTGCACCACCAA 3'
antisense: 5' GTCATITGAGAGCAATGCCAGC 3'
Determination of iNOS mRNA half life
Quiescent MCs were incubated for eight hours with TNF-a (25
nglml) plus IL-1/3 (25 U/mi) (5 Petri dishes), TNF-a plus IL-ill
plus transforming growth factor-Il (TGF-13) (5 ng/ml; 5 Petri
dishes) or TNF-cs plus IL-i/I plus ET-1 (108 M; 5 Petri dishes).
Actinomycin D (Act D) (10 jkg/ml) was added at different time
points (0 to 120 mm) before harvesting the cells for total RNA
isolation. RNA was electrophoresed and subjected to Northern
blot analysis with the labeled eDNA's for iNOS or GAPDH, as
described above. Relative iNOS mRNA content was determined
calculating the ratio of arbitrary videodensitometrical units ob-
tained for the signals of iNOS versus GAPDH within one blot
which was re-exposed several times to ensure linearity of the
samples obtained.
Detection of iNOS protein by Western blotting
Preparation of MC iysates and immunoblot analysis was per-
formed using time-matched 100 mm plates of MCs. They were
incubated with complete medium containing 0.1% bovine serum
albumin without FCS, medium supplemented with TNF-a (25
ng/ml) plus IL-i/I (25 U/mi), or medium supplemented with
TNF-a plus IL-i/I plus ET-1 (10—s M). After 24 hours of
incubation, the medium was removed. The plates were washed
twice with ice-cold phosphate-buffered saline and 1 ml of boiling
lysis solution (1% SDS, 10 mM Tris pH 7.4) was added directly to
the cells. The cell lysates were collected in centrifuge tubes and
protein contents were determined using the BCA Protein Assay
Reagent (Pierce, MUnchen, Germany). The samples (50 itg) were
diluted in electrophoresis sample buffer (250 mrvi Tris pH 6.8, 4%
SDS, 10% glycerol, 0.006% bromophenol blue, 2% /3-mercapto-
ethanol), boiled for five minutes, and resolved by electrophoresis
through 0.1% SDS-10% polyacrylamide gels. Proteins were elec-
trophoretically transferred to nitro-cellulose membranes and the
transfer efficiency was determined by staining the membranes with
Ponceau S. After destaining in distilled water, the membranes
were quenched in blocking solution (10% powdered dried low fat
milk in washing solution [10 mvi Tris pH 7.5, 100 mivi NaCl, 0.1%
Tween 20]) overnight at 4°C. The blocking solution was decanted,
membranes were incubated for one hour at room temperature
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Fig. 1. N02 production of MCs affected by TNF-a, IL-i I and ET-i. ET-1
and L-NMMA inhibit the synergistic upregulation of N02 formation by
TNF-cs plus IL-i/I. NO2- concentrations were measured in quiescent MCs
incubated for 24 hours with the indicated agents (25 nglml TNF-n [TI, 25
U/mI IL-i/I [II, i0 M ET-1, 1 mtvi L-NMMA or vehicle as control). N02
concentrations were determined in the supernatant by the Griess reaction.
The value was corrected for the total protein content per plate. Data
(mean so) represent three (T, T+I+ET-1) or four (C, I, T+I,
T+I+L-NMMA) experiments with assays performed in triplicate. *p <
0.05 for I, T+I, T+I+ET-1 versus control; P < 0.05 for T+I versus I; &p
< 0.05 for T+I versus T+J+ET-1.
with an anti-iNOS antibody, raised in rabbits [Affiniti, Notting-
ham, UK; 1:250 diluted in a second blocking solution (5%
powdered dried low fat milk in washing solution)]. Membranes
were washed for 30 minutes with several changes of washing
solution at room temperature. The bound primary antibody was
detected with a secondary antibody as described in the enhanced
chemiluminescence protocol (Amersham, Braunschweig, Ger-
many) using a horseradish peroxidase-conjugated anti-rabbit IgG
(Serva, Heidelberg, Germany) as secondary antibody (diluted
1:2,000 in the second blocking solution). We also applied a second
protocol to detect iNOS proteins using as primary antibody guinea
pig IgG directed against murine iNOS protein (provided by S.
Bachmann, Heidelberg, Germany) which was diluted 1:250 in the
second blocking solution. Goat anti-guinea pig horseradish per-
oxidase-conjugated IgG (Dianova, Hamburg, Germany) was used,
diluted 1:5,000, to detect bound guinea pig IgG using the above
protocol.
Statistical analysis
When suitable, means and SD5 were determined. Student's t-test
or analysis of variance (ANOVA), where applicable, were used to
test for statistically significant differences (P values < 0.05).
Results
N02 production of cytokine treated MCs
The stable metabolite of NO, N02 was determined in super-
natants of cultured MCs treated with IL-1J3 (25 U/mI), TNF-cs (25
ng/ml) or TNF-u plus IL-1/3. Supernatants of untreated MCs were
used as controls. As shown in Figure 1, incubation of MCs with
TNF-a plus IL-1/3 for 24 hours resulted in a higher N02 content
(277 74 nmol/mg protein) compared to IL-1/3 alone (67 11
nmol/mg protein). TNF-a (25 ng/ml) had no measurable effect (4
8 vs. 8 2 nmol/mg protein of untreated control cells). N02
formation stimulated by IL-i/3 or by TNF-a plus IL-1/3 was greatly
reduced (46 34 nmol/mg protein) by coincubation with I mtvi of
Fig. 2. Northern blot showing the synergistic effect ofTNF-a (T) plus IL -1 (3
(I) on iNOS gene transcription (A) and inhibition of TNF-a plus IL-i (3
induced iNOS transcription by ET-i (B). Treatment of MCs for 15 hours
with mediators (25 ng/ml TNF-a [TI, 25 U/mI IL-i/I [II, 1O M FT-i, or
vehicle as control [) was followed by cell harvesting for total RNA
isolation or protein extraction. RNA was electrophoresed and transferred
to nylon membranes. iNOS mRNA was detected by hybridization using
32P-labeled eDNA of the murine iNOS clone piNOS B2. Variation of
RNA content of each lane was controlled by rehybridization with a
GAPDH eDNA probe.
the stable L-arginine analog, L-NMMA, a competitive inhibitor of
NO synthesis indicating that N02 formation was dependent on
an L-arginine converting enzyme. When MCs were incubated with
TNF-a plus IL-1f3 and additionally with ET-1 (108 M) for 24
hours, MC formation of N02 was significantly reduced to 87
23 nmol/mg protein.
Effects on iNOS mRNA expression
To test whether the stimulation of N02 production is paral-
leled by changes of the iNOS mRNA level, Northern blot analysis
of iNOS transcription was performed with electrophoretically
separated total RNA obtained from MCs incubated with the
employed cytokines or vehicle for 15 hours. No iNOS mRNA
signal was detected in untreated cells and in MCs incubated with
TNF-cs (Fig. 2A). IL-i /3 by itself produced a poorly detectable
signal whereas use of both cytokines combined caused strong
hybridization showing an iNOS mRNA band at the expected 4 kb
size. When increasing concentrations of IL-1j3 were coincubated
with 10 nglml TNF-a, maximal iNOS mRNA hybridization signals
were detected at a concentration of 85 U/mI of IL-1f3 (Table 1). In
contrast, TNF-cs alone had no effect on iNOS induction even
when used at concentrations up to 100 nglml (data not shown).
ET-1 markedly reduced or even abolished the iNOS mRNA signal
in MCs treated with TNF-a plus IL-1/3 (Fig. 2B).
Effects on expression of iNOS protein
Western analysis was performed with two different anti-iNOS
antibodies on cell lysates prepared from either untreated MCs,
MCs treated with TNF-cs (25 ng/ml) plus IL-1/3 (25 U/mI) or with
TNF-a plus IL-I/I and FT-I (108 M). Combined stimulation with
the cytokines showed the expected 130 kD band for the iNOS
protein (Fig. 3). No signal was detectable in either the untreated
MC lysates or with coincubation of MCs with cytokines and ET-i.
This demonstrated that the cytokine-stimulated expression of the
iNOS protein paralleled the iNOS mRNA levels and that both
were strongly inhibited by ET-1.
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Fig. 3. Immunoblot analysis for iNOS protein under denaturing conditions.
Lane 1 shows lysates (50 pg protein) of untreated MCs (C), lane 2 shows
MCs stimulated with cytokines (25 nglml TNF-cs, 25 U/mI IL-lp) for 20
hours and lane 3 cytokine-stimulated MCs coincubated with 10—8 M ET-1.
A 130 kD band was clearly visible only in lane 2, indicating the expression
of iNOS protein. The immunoblot shown was obtained by use of an iNOS
antibody raised in rabbits (Affiniti, Nottingham, UK). Applying an iNOS
antibody raised in guinea-pig (gift from Dr. Bachmann, Heidelberg,
Germany) produced comparable bands.
Analysis of the inhibition of iNOS mRNA induction
Dose-dependency of the inhibitory effect of ET-1 on iNOS
mRNA expression was determined by Northern blot analysis with
MCs treated for 15 hours with TNF-a plus IL-1f3 and coincubated
with different concentrations of ET-1. The maximal inhibitory
effect was observed at an ET-1 concentration of i0 M (Fig. 4).
Use of shorter periods of coincubation (4 to 10 hr) of ET-1 with
TNF-cs plus IL-113 showed that a minimum of four hours was
required for inhibition of iNOS mRNA induction by ET-1 (data
not shown). The action of ET-1 on iNOS induction was further
analyzed in the presence and absence of Act D, an inhibitor of
RNA synthesis. For comparison with ET-1, TGF-/3 was also used
since Pfeilschifter and Vosbeck [23] have reported that TGF-f3
inhibits the expression of iNOS when induced by cytokines in rat
MCs. MCs were treated with TNF-s plus IL-ip and additionally
with either ET-1 (10 M), TGF-j3 (5 nglml) or with vehicle
control during eight consecutive hours. Act D (10 .tgIml) was
added at different time points before RNA isolation. The autora-
diograms of the Northern blots (Fig. SB) and the time course of
the densitometric readings (Fig. 5A) revealed decreasing iNOS
mRNA levels with prolonged Act D treatment. These data
indicated that the half-life of MC iNOS mRNA induced by TNF-cs
plus IL-1j3 was less than two hours. In the absence of Act D,
TGF-p was found to reduce transcription of iNOS to less than
50% of the control level. In addition, TGF-/3 accelerated the
breakdown of transcribed iNOS mRNA during the initial 30
minutes. Since iNOS transcription was almost completely pre-
vented by ET-1 even in the absence of Act D, we were unable to
assess an effect of ET-1 on the stability of iNOS mRNA.
Analysis of ET receptors
At least two ET receptors have been reported to mediate ET-1
induced effects in target cells [24, 25]. We used the ETA receptor-
selective agonist 56b and the ETB receptor-selective agonist S6c
[26, 27] as well as the ETA receptor antagonist BQ-123 [28] to
examine the receptor specificity of the inhibitory effect of ET-1 on
iNOS mRNA transcription in MCs. As shown in Figure 6A, S6b
and ET-1 (in concentrations between i0— and iO M) com-
pletely abolished the iNOS mRNA signal induced by TNF-a plus
IL-113. By Northern blotting, S6c showed neither significant
inhibition nor stimulation of iNOS transcription (Fig. 6). This was
assessed by densitometric evaluation of iNOS versus GAPDH
mRNA in five separate experiments. For the representative blot
shown in Figure 6A, the densitometric ratios iNOS versus
GAPDH were for S6c (10 M) 0.78, for 56c (108 M) 0.52 and for
Fig. 4. Dose response curve of the inhibitoy effect of ET-1 on iNOS mRNA
transcription. The signals for mRNA of iNOS and GAPDH from MCs
treated for 15 hours with 25 ng/ml TNF-a plus 25 U/mI IL-f3 and the
indicated concentrations of ET-1 were calculated by densitometiy. The
iNOS/GAPDH ratio of the densitometric readings obtained in the pres-
ence of TNF-cs plus IL-113 without ET-1 was set to 100%.
the control (T+I) 0.78. The effect of S6b (no iNOS signal
detectable) was partly reversible by preincubation for one hour
with the ETA receptor antagonist BQ-123 (10—v M iNOS/
GAPDH ratio = 0.69). Overexposure of the iNOS mRNA-labeled
filter revealed a partial reversion of the inhibitory ET-1 effect by
BQ-123 more clearly (Fig. 6B).
Discussion
Contractile MCs play an important role in the regulation of
glomerular hemodynamics and ultrafiltration [29]. Under physio-
logical conditions, glomerular blood flow, hydrostatic pressure,
and ultrafiltration are tightly regulated by the balance and inter-
play of vasoconstrictors (such as angiotensin II and ETs) and
vasodilators (such as prostaglandins and NO). It is well known
that MCs produce and are responsive to vasoactive substances as
well as to inflammatory cytokines. During glomerular inflamma-
tion, multiple cytokines have been described to affect the MC
phenotype. IL-13 and TNF-a are known to induce many biolog-
ical responses in MCs, such as they stimulate MC proliferation
and cause formation and release of autocrine mediator substances
including NO [8, 12, 29, 30]. NO has been shown to affect the
phenotype of MCs in culture and in vivo which, in turn, may
influence the function of the glomerular capillary ultrafiltration
apparatus.
Besides beneficial effects, such as the prevention of intraglo-
merular thrombosis [311, induction of iNOS by endotoxin or
cytokines followed by prolonged NO production could also be
detrimental for glomerular function and structure. For example,
massive NO release following induction of iNOS could lead to a
marked relaxation of glomerular MCs as well as VSMCs of the
afferent and efferent arteriole causing reduction of glomerular
hydrostatic pressure and ultrafiltration. ET-1 is a strong pressor
substance secreted by the vascular endothelium. ET-1 opposes the
vasodilatory effect of NO by direct vasoconstriction. Conceivably,
ET-l may also prevent inappropriate vasodilatation due to cyto-
kine-stimulated excess NO formation within the glomerulus by
downregulating iNOS expression in MCs. To investigate this
question we studied the effects of ET-1 on the induction of iNOS
caused by TNF-a and IL-113 in cultured MCs.
Synergistic effects of TNF-cs and IL-1J3 on iNOS expression and
formation of NO in MCs have been reported previously [8, 32]. In
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Fig. 5. Comparison of the inhibitory effects of ET-1 and TGF-13 on iNOS
mRNA transcription induced by TNF-o plus IL-i l3 Quiescent MCs were
treated with TNF-a (25 nglml) plus IL-1j3 (25 U/mI) (, T + I) and
additionally with either ET-1 (10 M; T + i + ET-1, ) or TGF-f3 (5
nglml; T + i + TGF-13, ) for eight hours. Act D (10 jsglml) was added
at the indicated time periods before cell harvesting, RNA isolation and
Northern blot analysis of total RNA. The intensities of the resulting bands
were quantified by videodensitometry and ratios of iNOS/GAPDH bands
were calculated setting maximal iNOS transcription induced by TNF-o
plus IL-113 without inhibitors to 100% (A). The autoradiograms of the
blotted RNA's, hybridized with piNOS B2 or GAPDH are displayed in
(B). The data shown represent one of two similar experiments.
the MC culture system used in the present study, induction of
iNOS was not detectable for TNF-a and was weak for IL-113, as
long as these cytokines were administered separately. However,
coincubation of MCs with both cytokines led to strong expression
of iNOS mRNA and protein. Synergistic upregulation of iNOS in
various types of cultured rat or human cells by two or more
cytokines (with or without endotoxin) has been observed by many
investigators. These effects are commonly explained by the as-
sumption that more than one pathway is necessary to yield
maximal iNOS induction by cytokines [11]. Using coincubation of
MCs with TNF-a plus IL-1f3 for up-regulation of iNOS mRNA,
we investigated the effects of ET-1 on iNOS expression in MCs.
We found that ET-1 inhibited cytokine-induced iNOS expres-
sion on the mRNA level in MCs in a dose-dependent fashion. The
inhibitory effect was observed when ET-1 was given simulta-
neously or at least two hours before and up to five hours after
cytokine treatment (data not shown). These findings strongly
argue for a specific effect of ET-1 on iNOS expression and against
ET-1 exerting inhibitory effects through changes in cytokine
receptor expression. The production of NO by MCs was also
greatly reduced by ET-1. Indeed, we observed that ET-1 inhibits
N02 accumulation in the MC culture supernatant to a similar
extent as caused by the inhibitor of NOS activity, L-NMMA (Fig.
1).
To gain further insight into the mechanism of iNOS inhibition
elicited by ET-1, we compared its action to that of TGF-/3, for
which posttranscriptional inhibitory effects on iNOS expression
have recently been described [23, 33]. The almost complete
prevention of iNOS mRNA induction in the presence of ET-1
indicates that ET-1 suppressed transcription of iNOS mRNA or
led to unstable iNOS mRNA with rapid degradation. An addi-
tional post-transcriptional effect, causing further down-regulation
of the iNOS mRNA seems unlikely since ET-1 was unable to
induce degradation of transcribed iNOS mRNA. In preliminary
studies, we found that ET-1 when given 15 to 22 hours after the
addition of TNF-s plus IL-113 did not diminish iNOS mRNA
content over a period of one to eight hours (data not shown).
Inhibition of iNOS mRNA expression by TGF-j3 in endotoxin-
stimulated murine macrophages has been shown to occur at
transcriptional as well as post-transcriptional levels [33]. In our
experiments, TGF-p caused partial inhibition of TNF-cs plus
IL-1f3-induced transcription of iNOS mRNA. In addition, in the
presence of TGF-13, we observed accelerated degradation of the
transcribed iNOS mRNA. Since TGF-/3 up-regulates prepro-ET-1
gene expression, the possibility exists that TGF-f3 down-regulates
iNOS expression in part through ET-1 REF [34]. In this study, we
did not measured ET-1 produced endogenously by MCs. Under
A
z
E
(I)02
E
0
100
75
50
25
0
0 30 60
Time, minutes
B
90 120
T+l iNOS
GAPDH
T-1-I
INOS
TGF-
GAPDH
T+I NOS
ET-1
GAPDH
0 15 30 60 120
Actinomycin D treatment, minutes
S S*
V so.
1898
+ —
C
.o
.E Oh—>0W
Beck et al: ET-1 inhibits iNOS transcription
C,)
c'j
a
+
q' ''o o 0 0
o o o 0
CC (C) CC) CC)
U) U) U) U)
the experimental conditions used, we found no evidence that ET-1
exerts a post-transcriptional effect to regulate NO production
beyond the iNOS mRNA level. The inhibition of iNOS transcrip-
tion by ET-1 is also supported by the observation that reduction of
iNOS protein expression and iNOS activity (as assessed by N02
accumulation) paralleled iNOS mRNA levels (Figs. 1 and 2).
Recently, Owada et al [35] have shown that activation of the
ETB receptor by ET-3 or by the selective ETB agonist IRL 1620
increased cGMP formation in cultured rat MCs in the presence of
20% FCS. This effect reached a maximum within five minutes
after addition of the agonists and was inhibitable by L-NMMA.
The authors concluded that calcium-dependent NO release was
responsible for cGMP formation and that a ET-3-activated,
calmodulin-dependent cNOS isoform is present in MCs. The MCs
used in our study also reacted to the ETB selective agonist S6c
with increased N02 production (inhibitable by L-NMMA) as
long as they were maintained in medium containing 10% FCS
(data not shown). This confirms the results of Owada et a! [35]
indicating the presence of ETB receptors and a constitutive NOS
in growing MCs. However, we were unable to detect N02
formation in quiescent MCs which were maintained in 0.5% FCS
for four days before incubation with S6c (data not shown). It is
possible that additional growth factors which are present in 10%
FCS or produced by growing MCs are necessary to permit NO
generation elicited via the ET8 receptor. The ETA selective
agonist S6b showed no effect on N02 production independent
from the presence of FCS (data not shown). However, S6b
inhibited iNOS transcription induced by TNF-cx plus IL-1f3 in a
manner similar to ET-1, indicating that the ETA receptor is
responsible for this effect. The available data support the concept
that ETs act on MCs via two different receptors. First, by
activating a constitutive, calcium and calmodulin-dependent NOS
via the ETB receptor [35]. This activation and subsequent NO
formation is short-lived and subject to tight control. Second, by
inhibiting a cytokine-induced calcium and calmodulin-indepen-
dent NOS via the ETA receptor preventing the production of
large amounts of NO over longer time periods.
In summary, our findings in MCs demonstrate that the vaso-
constrictor ET-1 can block the induction of iNOS by cytokines and
prevent the excess formation of vasorelaxant NO. The inhibition
is mediated via the ETA receptor. The precise mechanisms of
action and the biological relevance of the inhibitory effect of ET-1
on iNOS expression and NO production are presently unclear.
With regard to maintenance of the glomerular microcirculation, it
is conceivable that this action of ET-1 may serve to protect
glomerular ultrafiltration by inhibiting prolonged production of
large amounts of vasodilatory NO by MCs. This may be of
relevance in states of endotoxin excess with systemic or local
overproduction of TNF-cs and IL-113, as seen in sepsis and acute
glomerular inflammation.
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